| Code | Description | Claims | Beneficiaries | Total Paid |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
519,824 |
405,719 |
$34.16M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
48,841 |
44,988 |
$16.39M |
| J9271 |
Injection, pembrolizumab, 1 mg |
1,733 |
1,169 |
$7.29M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
40,663 |
38,721 |
$5.15M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
113,315 |
106,133 |
$4.08M |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
32,610 |
31,729 |
$2.96M |
| J9299 |
Injection, nivolumab, 1 mg |
722 |
448 |
$2.86M |
| D7140 |
Extraction, erupted tooth or exposed root |
1,118 |
921 |
$2.55M |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
4,315 |
3,092 |
$2.43M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
18,997 |
17,868 |
$2.37M |
| 77386 |
|
10,910 |
930 |
$2.36M |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
18,912 |
9,946 |
$2.25M |
| 76819 |
Fetal biophysical profile; without non-stress testing |
38,507 |
23,343 |
$2.02M |
| J2505 |
Injection, pegfilgrastim, 6 mg |
1,030 |
686 |
$1.95M |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
3,491 |
3,360 |
$1.78M |
| J1745 |
Injection, infliximab, excludes biosimilar, 10 mg |
1,043 |
950 |
$1.78M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
60,960 |
56,439 |
$1.73M |
| Q5104 |
Injection, infliximab-abda, biosimilar, (renflexis), 10 mg |
873 |
749 |
$1.65M |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
5,415 |
5,157 |
$1.54M |
| 90791 |
Psychiatric diagnostic evaluation |
29,128 |
17,779 |
$1.51M |
| 99215 |
Prolong outpt/office vis |
25,149 |
23,862 |
$1.50M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
16,656 |
13,993 |
$1.48M |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
3,085 |
2,968 |
$1.45M |
| 93303 |
Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study |
7,020 |
6,764 |
$1.42M |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
15,768 |
11,129 |
$1.26M |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
10,359 |
5,329 |
$1.16M |
| 99233 |
Prolong inpt eval add15 m |
31,714 |
12,657 |
$1.15M |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
2,312 |
2,278 |
$1.10M |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
42,738 |
16,423 |
$1.02M |
| D0150 |
Comprehensive oral evaluation - new or established patient |
1,264 |
1,157 |
$971K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
9,244 |
8,872 |
$931K |
| 90832 |
Psychotherapy, 30 minutes with patient |
15,486 |
11,297 |
$923K |
| 77412 |
|
10,791 |
1,111 |
$911K |
| J0178 |
Injection, aflibercept, 1 mg |
1,074 |
1,017 |
$880K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
3,116 |
3,012 |
$784K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
3,666 |
3,555 |
$781K |
| 77334 |
|
2,477 |
1,787 |
$731K |
| D2930 |
Prefabricated stainless steel crown - primary tooth |
826 |
802 |
$728K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
12,263 |
11,986 |
$721K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
15,837 |
14,624 |
$720K |
| C8929 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
3,708 |
3,538 |
$661K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
5,473 |
5,292 |
$656K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
4,948 |
4,840 |
$633K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
10,741 |
10,063 |
$630K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
9,495 |
9,268 |
$618K |
| 71046 |
Radiologic examination, chest; 2 views |
16,917 |
15,977 |
$613K |
| J9312 |
Injection, rituximab, 10 mg |
204 |
116 |
$593K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
17,376 |
16,708 |
$562K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
8,507 |
5,336 |
$560K |
| 67028 |
Intravitreal injection of a pharmacologic agent |
8,275 |
7,303 |
$534K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
22,210 |
8,390 |
$508K |
| 70450 |
Computed tomography, head or brain; without contrast material |
7,351 |
6,839 |
$506K |
| J7298 |
Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg |
617 |
570 |
$482K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
21,529 |
13,523 |
$475K |
| G0008 |
Administration of influenza virus vaccine |
18,442 |
18,122 |
$443K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
3,311 |
3,213 |
$432K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
9,089 |
5,390 |
$431K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
7,201 |
6,999 |
$429K |
| 95911 |
|
2,858 |
2,788 |
$415K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
16,157 |
12,153 |
$412K |
| J0897 |
Injection, denosumab, 1 mg |
815 |
648 |
$406K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
4,915 |
3,580 |
$382K |
| 77300 |
|
2,130 |
1,805 |
$367K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
4,472 |
4,292 |
$358K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
5,039 |
4,843 |
$357K |
| J1459 |
Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg |
176 |
82 |
$356K |
| 95708 |
|
1,116 |
505 |
$350K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
21,415 |
18,939 |
$349K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
1,132 |
1,084 |
$341K |
| 96367 |
|
9,761 |
5,634 |
$335K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
12,033 |
8,146 |
$319K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
8,033 |
7,187 |
$317K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
8,326 |
8,045 |
$316K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
73,558 |
65,692 |
$312K |
| 52000 |
|
1,831 |
1,749 |
$306K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
8,048 |
7,151 |
$302K |
| 99223 |
Prolong inpt eval add15 m |
4,402 |
4,268 |
$298K |
| 77336 |
|
6,419 |
2,710 |
$297K |
| G0379 |
Direct admission of patient for hospital observation care |
250 |
243 |
$291K |
| 20610 |
|
2,850 |
2,520 |
$287K |
| 99205 |
Prolong outpt/office vis |
2,735 |
2,684 |
$284K |
| 43235 |
|
862 |
821 |
$283K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
27,523 |
18,743 |
$282K |
| 95811 |
|
716 |
704 |
$281K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
2,130 |
2,045 |
$278K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
2,720 |
2,666 |
$277K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
7,481 |
3,615 |
$270K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
4,246 |
4,146 |
$266K |
| 95886 |
|
12,158 |
11,877 |
$263K |
| 76830 |
Ultrasound, transvaginal |
3,536 |
3,417 |
$261K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
4,254 |
3,966 |
$247K |
| 96116 |
|
1,505 |
1,489 |
$244K |
| J1453 |
Injection, fosaprepitant, 1 mg |
2,377 |
1,340 |
$240K |
| 64642 |
|
1,472 |
1,435 |
$240K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
3,677 |
3,618 |
$233K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
4,809 |
4,712 |
$231K |
| 74183 |
|
1,752 |
1,694 |
$224K |
| 95819 |
|
1,354 |
1,320 |
$223K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
3,331 |
3,264 |
$222K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
5,606 |
3,273 |
$222K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
4,371 |
4,306 |
$215K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
2,536 |
2,433 |
$211K |
| 95909 |
|
2,324 |
2,278 |
$209K |
| J1439 |
Injection, ferric carboxymaltose, 1 mg |
652 |
541 |
$207K |
| 92587 |
|
1,021 |
1,000 |
$206K |
| J9305 |
Injection, pemetrexed, not otherwise specified, 10 mg |
86 |
52 |
$203K |
| 93454 |
|
230 |
221 |
$202K |
| 72141 |
|
1,591 |
1,550 |
$202K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
4,690 |
4,554 |
$201K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
3,772 |
3,420 |
$199K |
| 96416 |
|
1,517 |
794 |
$196K |
| 77301 |
|
419 |
392 |
$193K |
| J1950 |
Injection, leuprolide acetate (for depot suspension), per 3.75 mg |
159 |
140 |
$186K |
| 96158 |
|
3,993 |
2,989 |
$184K |
| 71250 |
|
3,516 |
3,427 |
$184K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,946 |
2,853 |
$180K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
8,329 |
3,475 |
$175K |
| 95812 |
|
1,050 |
1,027 |
$174K |
| 90834 |
Psychotherapy, 45 minutes with patient |
3,018 |
2,291 |
$171K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
2,020 |
1,961 |
$171K |
| 90837 |
Psychotherapy, 53 minutes with patient |
2,333 |
1,603 |
$165K |
| 93971 |
|
3,400 |
3,207 |
$161K |
| 93924 |
|
2,479 |
2,401 |
$161K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
4,986 |
4,789 |
$159K |
| Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) |
834 |
617 |
$157K |
| J0185 |
Injection, aprepitant, 1 mg |
1,219 |
720 |
$156K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
6,707 |
6,299 |
$155K |
| 76770 |
|
2,554 |
2,503 |
$153K |
| 96415 |
|
4,499 |
2,899 |
$149K |
| 72197 |
|
450 |
436 |
$147K |
| 95910 |
|
1,777 |
1,728 |
$142K |
| 96132 |
|
1,158 |
1,138 |
$142K |
| 31575 |
|
1,905 |
1,818 |
$141K |
| 93296 |
|
11,754 |
11,570 |
$141K |
| 73221 |
|
1,188 |
1,156 |
$139K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
405 |
388 |
$138K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
12,316 |
11,255 |
$137K |
| 0002A |
|
5,840 |
5,655 |
$137K |
| 90473 |
|
3,106 |
3,075 |
$136K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
4,676 |
3,068 |
$136K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
7,081 |
3,846 |
$133K |
| 36561 |
|
126 |
121 |
$132K |
| 96130 |
|
3,225 |
3,179 |
$130K |
| 96417 |
|
4,682 |
2,696 |
$129K |
| 93970 |
|
1,432 |
1,368 |
$128K |
| 0001A |
|
6,093 |
5,950 |
$125K |
| 97803 |
|
5,693 |
5,350 |
$123K |
| 92557 |
|
2,140 |
2,069 |
$123K |
| J9217 |
Leuprolide acetate (for depot suspension), 7.5 mg |
668 |
613 |
$120K |
| 76801 |
|
1,542 |
1,455 |
$119K |
| J0475 |
Injection, baclofen, 10 mg |
727 |
689 |
$115K |
| 71045 |
Radiologic examination, chest; single view |
5,104 |
4,487 |
$115K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
10,395 |
10,099 |
$115K |
| 93880 |
|
2,159 |
2,085 |
$115K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
10,405 |
10,108 |
$114K |
| G0260 |
Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography |
460 |
383 |
$114K |
| 77338 |
|
967 |
821 |
$114K |
| 97161 |
|
2,730 |
2,655 |
$112K |
| 77295 |
|
248 |
224 |
$111K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
27 |
26 |
$108K |
| 90686 |
|
12,567 |
12,338 |
$108K |
| 00170 |
Anesthesia for intraoral procedures, including biopsy |
1,023 |
992 |
$107K |
| Q5118 |
Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg |
58 |
38 |
$106K |
| 58661 |
|
29 |
26 |
$104K |
| J7307 |
Etonogestrel (contraceptive) implant system, including implant and supplies |
113 |
109 |
$98K |
| 94010 |
|
4,073 |
3,909 |
$94K |
| J2997 |
Injection, alteplase recombinant, 1 mg |
883 |
658 |
$91K |
| 93923 |
|
2,709 |
2,604 |
$91K |
| J2777 |
Injection, faricimab-svoa, 0.1 mg |
166 |
82 |
$89K |
| 64615 |
|
880 |
851 |
$88K |
| 77290 |
|
721 |
605 |
$88K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
2,133 |
2,061 |
$87K |
| 43249 |
|
156 |
149 |
$85K |
| 51705 |
|
1,320 |
1,094 |
$83K |
| 94726 |
|
1,344 |
1,308 |
$82K |
| 76536 |
|
1,456 |
1,419 |
$81K |
| J2506 |
Injection, pegfilgrastim, excludes biosimilar, 0.5 mg |
76 |
54 |
$81K |
| 77066 |
Tomosynthesis, mammo |
1,172 |
1,141 |
$79K |
| 76642 |
|
2,383 |
2,228 |
$78K |
| 99220 |
|
1,016 |
983 |
$77K |
| 96101 |
|
763 |
755 |
$77K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
98 |
97 |
$74K |
| 95700 |
|
590 |
583 |
$74K |
| 62369 |
|
1,068 |
1,004 |
$74K |
| Q3014 |
Telehealth originating site facility fee |
5,753 |
5,174 |
$74K |
| 97162 |
|
2,226 |
2,151 |
$73K |
| 93225 |
|
1,856 |
1,808 |
$72K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
2,933 |
2,888 |
$70K |
| 95953 |
|
263 |
125 |
$70K |
| J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) |
654 |
430 |
$69K |
| 96411 |
|
2,084 |
1,290 |
$69K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
48,130 |
43,628 |
$67K |
| 93017 |
|
3,702 |
3,551 |
$67K |
| 72100 |
|
3,299 |
3,216 |
$66K |
| 93798 |
|
1,430 |
261 |
$66K |
| 90677 |
|
1,431 |
1,403 |
$66K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
2,387 |
2,114 |
$65K |
| D2929 |
|
71 |
71 |
$65K |
| 96131 |
|
3,173 |
3,126 |
$63K |
| 97163 |
|
2,340 |
2,244 |
$63K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
14,423 |
13,204 |
$62K |
| 84443 |
Thyroid stimulating hormone (TSH) |
19,578 |
18,086 |
$61K |
| G2212 |
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99205, 99215, 99483 for office or other outpatient evaluation and management services) (do not report g2212 on the same date of service as 99358, 99359, 99415, 99416). (do not report g2212 for any time unit less than 15 minutes) |
1,525 |
1,483 |
$61K |
| 92523 |
|
514 |
504 |
$59K |
| 80053 |
Comprehensive metabolic panel |
97,512 |
76,151 |
$59K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
8,309 |
8,079 |
$58K |
| 64493 |
|
130 |
119 |
$58K |
| 70491 |
|
441 |
428 |
$58K |
| 99222 |
Initial hospital care, per day, moderate complexity |
1,118 |
1,080 |
$54K |
| 96152 |
|
649 |
481 |
$53K |
| 99495 |
|
999 |
978 |
$53K |
| 36593 |
|
431 |
318 |
$52K |
| 93295 |
|
3,265 |
3,222 |
$52K |
| 59025 |
Fetal non-stress test |
421 |
344 |
$52K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
6,396 |
6,079 |
$51K |
| 93312 |
|
482 |
462 |
$51K |
| 52310 |
|
73 |
66 |
$51K |
| 77080 |
|
1,218 |
1,189 |
$50K |
| 72158 |
|
422 |
402 |
$49K |
| 73564 |
|
4,966 |
4,111 |
$49K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
6,064 |
5,729 |
$49K |
| 77065 |
Tomosynthesis, mammo |
1,070 |
1,027 |
$48K |
| 86900 |
|
4,773 |
4,041 |
$48K |
| 93320 |
|
7,886 |
7,607 |
$48K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
105,873 |
78,969 |
$47K |
| 74018 |
|
2,760 |
2,566 |
$46K |
| Q5122 |
Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg |
14 |
12 |
$46K |
| 92134 |
|
10,734 |
10,261 |
$46K |
| C8930 |
Transthoracic echocardiography, with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report; including performance of continuous electrocardiographic monitoring, with physician supervision |
152 |
144 |
$45K |
| 36430 |
|
275 |
160 |
$45K |
| 80061 |
Lipid panel |
6,453 |
6,244 |
$45K |
| 96118 |
|
337 |
333 |
$44K |
| 80055 |
|
1,814 |
1,770 |
$44K |
| 97802 |
|
1,476 |
1,447 |
$43K |
| 90732 |
|
730 |
712 |
$41K |
| J2778 |
Injection, ranibizumab, 0.1 mg |
210 |
166 |
$40K |
| 94060 |
|
299 |
294 |
$38K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
940 |
917 |
$37K |
| 99406 |
|
2,598 |
2,500 |
$37K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
454 |
444 |
$37K |
| D1120 |
Prophylaxis - child |
1,001 |
978 |
$37K |
| Q5108 |
Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg |
38 |
28 |
$36K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
1,511 |
1,473 |
$34K |
| 97167 |
|
1,242 |
1,192 |
$34K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
705 |
449 |
$34K |
| 73630 |
|
5,393 |
4,686 |
$32K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
1,863 |
1,304 |
$32K |
| 51702 |
|
1,483 |
1,329 |
$32K |
| 31231 |
|
363 |
352 |
$32K |
| 97166 |
|
765 |
748 |
$31K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
4,973 |
4,804 |
$31K |
| 00731 |
|
949 |
893 |
$30K |
| 72050 |
|
927 |
900 |
$30K |
| D3240 |
|
103 |
103 |
$30K |
| 96137 |
|
2,903 |
2,865 |
$30K |
| 36415 |
Collection of venous blood by venipuncture |
69,566 |
57,354 |
$30K |
| 19083 |
|
53 |
50 |
$29K |
| 70486 |
|
696 |
673 |
$29K |
| 88184 |
|
728 |
668 |
$29K |
| 76000 |
|
2,582 |
2,446 |
$29K |
| 62323 |
|
123 |
120 |
$28K |
| 64721 |
|
41 |
36 |
$28K |
| 97035 |
|
5,281 |
2,084 |
$27K |
| 73030 |
|
5,771 |
5,135 |
$27K |
| 93294 |
|
3,132 |
3,072 |
$27K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
16,917 |
15,639 |
$26K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
2,203 |
2,082 |
$25K |
| 73130 |
|
3,241 |
2,621 |
$25K |
| 90670 |
|
3,507 |
3,457 |
$24K |
| 84702 |
|
4,197 |
3,523 |
$23K |
| 93226 |
|
1,905 |
1,848 |
$23K |
| 87081 |
|
13,401 |
12,885 |
$23K |
| 73610 |
|
4,704 |
4,292 |
$23K |
| 95806 |
|
532 |
507 |
$23K |
| 76820 |
|
3,463 |
1,364 |
$22K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
471 |
452 |
$22K |
| 01922 |
|
554 |
542 |
$22K |
| 96136 |
|
3,245 |
3,204 |
$22K |
| 95251 |
|
1,081 |
1,049 |
$22K |
| 77470 |
|
114 |
104 |
$21K |
| 57454 |
|
107 |
103 |
$21K |
| 99226 |
|
333 |
199 |
$20K |
| 73502 |
|
3,505 |
3,344 |
$20K |
| 92060 |
|
1,649 |
1,626 |
$20K |
| 82728 |
|
9,977 |
9,187 |
$20K |
| 99490 |
Ccm add 20min |
657 |
643 |
$20K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
18,493 |
17,897 |
$19K |
| D1206 |
Topical application of fluoride varnish |
1,929 |
1,846 |
$19K |
| M0245 |
Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring |
83 |
82 |
$19K |
| 73110 |
|
2,271 |
2,098 |
$19K |
| 49083 |
|
67 |
25 |
$19K |
| 74174 |
|
227 |
224 |
$19K |
| 96150 |
|
177 |
169 |
$19K |
| 58300 |
|
310 |
278 |
$19K |
| 70544 |
|
149 |
142 |
$18K |
| 64643 |
|
1,041 |
1,009 |
$18K |
| 96138 |
|
1,241 |
1,218 |
$18K |
| D1351 |
Sealant - per tooth |
183 |
167 |
$18K |
| 95908 |
|
162 |
158 |
$18K |
| 96409 |
|
242 |
137 |
$18K |
| 93975 |
|
161 |
154 |
$18K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
53 |
44 |
$17K |
| 51700 |
|
190 |
119 |
$17K |
| 93271 |
|
328 |
320 |
$17K |
| 93280 |
|
1,881 |
1,832 |
$17K |
| 10060 |
|
132 |
125 |
$16K |
| 98927 |
|
3,054 |
2,801 |
$16K |
| 78306 |
|
115 |
112 |
$16K |
| 87390 |
|
2,231 |
2,176 |
$16K |
| 64483 |
|
52 |
50 |
$16K |
| 58301 |
|
85 |
77 |
$16K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
4,423 |
4,041 |
$16K |
| 73560 |
|
5,217 |
4,280 |
$16K |
| 87631 |
|
6,287 |
6,037 |
$16K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
900 |
851 |
$16K |
| 76870 |
|
395 |
380 |
$16K |
| 95816 |
|
283 |
260 |
$15K |
| 99188 |
|
1,050 |
1,031 |
$15K |
| 99460 |
|
279 |
273 |
$15K |
| 90651 |
|
1,359 |
1,323 |
$15K |
| 93456 |
|
13 |
12 |
$14K |
| 95874 |
|
2,834 |
2,732 |
$14K |
| 92579 |
|
433 |
426 |
$14K |
| 99496 |
|
247 |
242 |
$14K |
| 72070 |
|
633 |
608 |
$14K |
| 81025 |
|
15,398 |
14,380 |
$13K |
| 99479 |
Subsequent intensive care, per day, very low birth weight infant |
196 |
37 |
$13K |
| D2391 |
Resin-based composite - one surface, posterior, primary or permanent |
26 |
24 |
$13K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
855 |
733 |
$13K |
| 78431 |
|
28 |
25 |
$13K |
| 99443 |
|
425 |
421 |
$13K |
| P9047 |
Infusion, albumin (human), 25%, 50 ml |
159 |
71 |
$13K |
| 96402 |
|
2,274 |
1,992 |
$13K |
| 72082 |
|
440 |
430 |
$13K |
| G0433 |
Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 and/or hiv-2, screening |
1,364 |
1,340 |
$13K |
| 90734 |
|
990 |
933 |
$12K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
705 |
427 |
$12K |
| 93016 |
|
1,248 |
1,216 |
$12K |
| 76825 |
|
24 |
24 |
$12K |
| 88307 |
|
2,385 |
2,213 |
$12K |
| 83550 |
|
9,130 |
8,412 |
$11K |
| J1750 |
Injection, iron dextran, 50 mg |
82 |
78 |
$11K |
| 29075 |
|
65 |
56 |
$11K |
| 80305 |
|
17,372 |
13,874 |
$11K |
| 70496 |
|
131 |
120 |
$11K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
385 |
376 |
$11K |
| 93325 |
|
8,565 |
8,213 |
$11K |
| 64644 |
|
63 |
60 |
$11K |
| 83970 |
|
910 |
881 |
$11K |
| 85027 |
|
12,072 |
9,759 |
$11K |
| 72156 |
|
73 |
68 |
$11K |
| 82950 |
|
2,435 |
2,385 |
$11K |
| 0124A |
|
836 |
797 |
$10K |
| 73140 |
|
985 |
920 |
$10K |
| 50435 |
|
27 |
25 |
$10K |
| 82105 |
|
1,594 |
1,542 |
$10K |
| 88342 |
|
4,346 |
4,093 |
$10K |
| 86702 |
|
2,242 |
2,187 |
$10K |
| 87205 |
|
12,448 |
11,861 |
$9K |
| 83540 |
|
9,805 |
9,044 |
$9K |
| 0004A |
|
598 |
569 |
$9K |
| 72146 |
|
115 |
111 |
$9K |
| 86747 |
|
1,029 |
726 |
$9K |
| 58100 |
|
87 |
87 |
$9K |
| 72170 |
|
1,322 |
1,269 |
$9K |
| 91010 |
|
32 |
31 |
$9K |
| 90480 |
|
555 |
547 |
$9K |
| 78264 |
|
44 |
42 |
$9K |
| 82607 |
|
4,446 |
4,240 |
$9K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
325 |
302 |
$9K |
| 67210 |
|
34 |
27 |
$8K |
| 20553 |
|
58 |
54 |
$8K |
| 0054A |
|
536 |
516 |
$8K |
| 99385 |
|
120 |
117 |
$8K |
| 86701 |
|
2,245 |
2,186 |
$8K |
| 20611 |
|
115 |
110 |
$8K |
| 98926 |
|
1,519 |
1,425 |
$8K |
| 86803 |
|
3,493 |
3,411 |
$8K |
| 98928 |
|
1,672 |
1,592 |
$8K |
| 27096 |
|
151 |
147 |
$8K |
| 73521 |
|
408 |
397 |
$8K |
| 73080 |
|
964 |
883 |
$8K |
| 93018 |
|
1,249 |
1,217 |
$8K |
| 74178 |
|
54 |
53 |
$8K |
| C9257 |
Injection, bevacizumab, 0.25 mg |
2,561 |
2,216 |
$7K |
| 83655 |
|
1,520 |
1,453 |
$7K |
| 74230 |
|
112 |
107 |
$7K |
| 87522 |
Neg quan hep c or qual rna |
1,019 |
1,004 |
$7K |
| 99221 |
|
293 |
274 |
$7K |
| 73590 |
|
1,828 |
1,636 |
$7K |
| 80502 |
|
288 |
274 |
$7K |
| 73562 |
|
2,088 |
1,780 |
$7K |
| 93000 |
|
504 |
477 |
$7K |
| 95822 |
|
160 |
144 |
$7K |
| 93926 |
|
148 |
144 |
$7K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
15,742 |
9,812 |
$7K |
| 87077 |
|
8,852 |
8,407 |
$6K |
| 86850 |
|
5,176 |
4,422 |
$6K |
| 84439 |
|
3,985 |
3,648 |
$6K |
| 95913 |
|
40 |
39 |
$6K |
| 92250 |
|
1,695 |
1,654 |
$6K |
| 95951 |
|
51 |
24 |
$6K |
| 99217 |
|
173 |
167 |
$6K |
| 95938 |
|
62 |
56 |
$6K |
| 90656 |
|
893 |
886 |
$6K |
| 95941 |
|
40 |
39 |
$6K |
| G0009 |
Administration of pneumococcal vaccine |
1,151 |
1,127 |
$6K |
| 81003 |
|
28,288 |
25,581 |
$6K |
| 88360 |
|
739 |
691 |
$6K |
| 82677 |
|
319 |
314 |
$6K |
| G0378 |
Hospital observation service, per hour |
17,710 |
12,227 |
$6K |
| 72110 |
|
468 |
459 |
$5K |
| 92610 |
|
181 |
176 |
$5K |
| 97165 |
|
169 |
159 |
$5K |
| 96156 |
|
109 |
108 |
$5K |
| 93978 |
|
109 |
102 |
$5K |
| 86592 |
|
1,672 |
1,635 |
$5K |
| 93308 |
|
132 |
118 |
$5K |
| 87536 |
|
1,212 |
1,183 |
$5K |
| 73600 |
|
990 |
872 |
$5K |
| 73090 |
|
1,341 |
1,135 |
$5K |
| 99480 |
Subsequent intensive care, per day, low birth weight infant |
66 |
26 |
$5K |
| 86580 |
|
655 |
587 |
$5K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
12,635 |
12,027 |
$5K |
| 86140 |
|
11,306 |
10,525 |
$5K |
| 0071A |
|
232 |
158 |
$5K |
| 83735 |
|
30,231 |
21,586 |
$5K |
| 74019 |
|
430 |
414 |
$5K |
| 0072A |
|
233 |
139 |
$5K |
| 91320 |
|
230 |
227 |
$5K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
14,302 |
13,118 |
$5K |
| 92511 |
|
66 |
64 |
$5K |
| 93283 |
|
433 |
420 |
$5K |
| 86480 |
|
289 |
285 |
$5K |
| 75635 |
|
63 |
62 |
$5K |
| 76885 |
|
82 |
79 |
$5K |
| 99152 |
|
6,869 |
6,449 |
$4K |
| 81001 |
|
14,880 |
13,025 |
$4K |
| 94729 |
|
3,044 |
2,929 |
$4K |
| 96133 |
|
1,229 |
1,192 |
$4K |
| 93351 |
|
29 |
27 |
$4K |
| 69209 |
|
978 |
932 |
$4K |
| 93298 |
|
152 |
144 |
$4K |
| 82948 |
|
28,377 |
15,815 |
$4K |
| 96127 |
|
486 |
485 |
$4K |
| 76827 |
|
355 |
347 |
$4K |
| 99454 |
|
191 |
190 |
$4K |
| 97116 |
|
403 |
218 |
$4K |
| 86336 |
|
322 |
317 |
$4K |
| 90662 |
|
1,810 |
1,735 |
$4K |
| 90678 |
|
14 |
14 |
$4K |
| 87186 |
|
5,084 |
4,852 |
$4K |
| 76775 |
|
89 |
84 |
$4K |
| 74221 |
|
37 |
37 |
$4K |
| 90716 |
|
1,355 |
1,341 |
$4K |
| 82746 |
|
1,965 |
1,878 |
$4K |
| 96146 |
|
823 |
801 |
$3K |
| 91322 |
|
106 |
105 |
$3K |
| P9040 |
Red blood cells, leukocytes reduced, irradiated, each unit |
17 |
12 |
$3K |
| 92235 |
|
42 |
42 |
$3K |
| 87150 |
|
254 |
250 |
$3K |
| 69210 |
|
1,635 |
1,563 |
$3K |
| 82784 |
|
3,812 |
3,417 |
$3K |
| C8924 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, follow-up or limited study |
30 |
28 |
$3K |
| 36591 |
|
382 |
278 |
$3K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
14 |
14 |
$3K |
| 51798 |
|
4,787 |
4,539 |
$3K |
| 85610 |
|
21,441 |
13,408 |
$3K |
| 92611 |
|
96 |
92 |
$3K |
| 82570 |
|
2,504 |
2,264 |
$3K |
| 82947 |
|
1,174 |
1,132 |
$3K |
| 11982 |
|
12 |
12 |
$3K |
| 84153 |
|
2,082 |
1,887 |
$3K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
9,904 |
8,575 |
$3K |
| 73552 |
|
1,079 |
977 |
$3K |
| 99381 |
|
43 |
43 |
$3K |
| 87340 |
|
2,878 |
2,798 |
$3K |
| 86706 |
|
2,531 |
2,466 |
$3K |
| 85652 |
|
10,725 |
10,073 |
$3K |
| 84156 |
|
2,546 |
2,254 |
$3K |
| 72157 |
|
35 |
32 |
$3K |
| 29065 |
|
14 |
13 |
$3K |
| 96119 |
|
302 |
298 |
$2K |
| 93284 |
|
247 |
244 |
$2K |
| 93299 |
|
147 |
146 |
$2K |
| 80076 |
|
1,338 |
1,171 |
$2K |
| 84100 |
|
4,189 |
2,528 |
$2K |
| 82977 |
|
2,280 |
2,112 |
$2K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
6,119 |
5,555 |
$2K |
| 0052A |
|
90 |
75 |
$2K |
| 70498 |
|
159 |
150 |
$2K |
| 86481 |
|
455 |
440 |
$2K |
| 72040 |
|
859 |
824 |
$2K |
| 76882 |
|
41 |
40 |
$2K |
| 95115 |
|
227 |
86 |
$2K |
| 76981 |
|
139 |
134 |
$2K |
| 73700 |
|
40 |
37 |
$2K |
| 98929 |
|
376 |
353 |
$2K |
| 83516 |
|
1,373 |
1,201 |
$2K |
| 0031A |
|
112 |
108 |
$2K |
| 86704 |
|
1,932 |
1,887 |
$2K |
| 83690 |
|
10,250 |
9,372 |
$2K |
| 73100 |
|
1,270 |
1,080 |
$2K |
| 95117 |
|
133 |
62 |
$2K |
| 70355 |
|
567 |
528 |
$2K |
| 74220 |
|
25 |
25 |
$2K |
| 11981 |
|
28 |
25 |
$2K |
| 86038 |
|
1,220 |
1,188 |
$2K |
| 96401 |
|
698 |
405 |
$2K |
| 94070 |
|
12 |
12 |
$2K |
| 96160 |
|
103 |
103 |
$2K |
| 92002 |
|
44 |
43 |
$2K |
| 92015 |
Determination of refractive state |
2,560 |
2,512 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
4,865 |
4,725 |
$2K |
| 96161 |
|
70 |
70 |
$2K |
| 83993 |
|
178 |
172 |
$2K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
2,106 |
1,958 |
$2K |
| 85730 |
|
2,166 |
1,974 |
$2K |
| 71271 |
|
237 |
236 |
$2K |
| 00811 |
|
42 |
42 |
$2K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
4,552 |
4,353 |
$2K |
| 90746 |
|
32 |
32 |
$2K |
| 85018 |
|
3,883 |
3,090 |
$2K |
| 95937 |
|
30 |
29 |
$2K |
| 84403 |
|
138 |
134 |
$1K |
| 84600 |
|
253 |
246 |
$1K |
| 84163 |
|
611 |
600 |
$1K |
| 0051A |
|
59 |
54 |
$1K |
| 17110 |
|
38 |
37 |
$1K |
| 62370 |
|
16 |
13 |
$1K |
| 74160 |
|
12 |
12 |
$1K |
| 82803 |
|
2,053 |
1,741 |
$1K |
| 99397 |
|
122 |
111 |
$1K |
| 83880 |
|
2,810 |
2,595 |
$1K |
| 82565 |
|
3,602 |
3,409 |
$1K |
| 95955 |
|
13 |
12 |
$1K |
| 92083 |
|
220 |
212 |
$1K |
| 86618 |
|
838 |
818 |
$1K |
| 87070 |
|
2,781 |
2,666 |
$1K |
| 92133 |
|
254 |
247 |
$1K |
| 76821 |
|
202 |
117 |
$1K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
4,892 |
3,349 |
$1K |
| J2785 |
Injection, regadenoson, 0.1 mg |
2,458 |
2,368 |
$1K |
| 86360 |
|
847 |
832 |
$1K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
393 |
383 |
$1K |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
788 |
646 |
$1K |
| 85046 |
|
2,442 |
1,909 |
$1K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
10,625 |
9,910 |
$1K |
| 82951 |
|
84 |
84 |
$1K |
| 0081A |
|
39 |
28 |
$1K |
| 82043 |
|
1,706 |
1,639 |
$986.98 |
| 86359 |
|
935 |
917 |
$981.47 |
| 88304 |
|
1,541 |
1,486 |
$978.59 |
| 90710 |
|
693 |
676 |
$973.08 |
| 0011A |
|
208 |
199 |
$968.88 |
| 92567 |
|
3,233 |
3,125 |
$957.18 |
| 84550 |
|
2,088 |
1,853 |
$945.86 |
| 77072 |
|
26 |
25 |
$917.35 |
| 83615 |
|
4,530 |
3,716 |
$915.28 |
| 82550 |
|
2,055 |
1,855 |
$914.65 |
| 0012A |
|
110 |
103 |
$893.38 |
| 90620 |
|
313 |
305 |
$884.22 |
| 90681 |
|
649 |
637 |
$869.20 |
| 86160 |
|
322 |
297 |
$831.40 |
| 83001 |
|
141 |
133 |
$831.11 |
| 97597 |
|
21 |
12 |
$788.69 |
| 84460 |
|
809 |
790 |
$785.40 |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
13 |
13 |
$783.55 |
| J8501 |
Aprepitant, oral, 5 mg |
2,330 |
2,123 |
$779.52 |
| 84165 |
|
1,522 |
1,365 |
$778.06 |
| 77280 |
|
15 |
13 |
$765.78 |
| 74420 |
|
393 |
365 |
$755.65 |
| 92285 |
|
426 |
405 |
$754.48 |
| 0053A |
|
51 |
44 |
$731.41 |
| 87040 |
|
2,090 |
1,882 |
$693.66 |
| 84450 |
|
747 |
729 |
$692.23 |
| 72131 |
|
14 |
13 |
$680.82 |
| 82378 |
|
2,785 |
2,096 |
$668.01 |
| 0003A |
|
49 |
49 |
$665.76 |
| 84484 |
|
11,813 |
9,869 |
$653.28 |
| 92526 |
|
15 |
13 |
$643.61 |
| 73070 |
|
650 |
547 |
$642.39 |
| 71101 |
|
94 |
91 |
$632.80 |
| 84146 |
|
63 |
62 |
$631.27 |
| 83520 |
|
339 |
305 |
$625.06 |
| 99497 |
|
29 |
28 |
$613.87 |
| 0082A |
|
32 |
16 |
$612.32 |
| 81002 |
|
763 |
649 |
$590.97 |
| 01400 |
|
12 |
12 |
$578.44 |
| 99462 |
|
29 |
25 |
$568.75 |
| 83883 |
|
678 |
617 |
$563.84 |
| 80164 |
|
257 |
227 |
$556.56 |
| 93270 |
|
345 |
337 |
$553.41 |
| 86708 |
|
524 |
516 |
$548.84 |
| 88377 |
|
379 |
345 |
$539.11 |
| 81015 |
|
820 |
755 |
$531.21 |
| 82140 |
|
435 |
391 |
$513.90 |
| G0010 |
Administration of hepatitis b vaccine |
30 |
30 |
$507.50 |
| C2617 |
Stent, non-coronary, temporary, without delivery system |
508 |
483 |
$505.20 |
| 0074A |
|
17 |
14 |
$498.34 |
| 93227 |
|
45 |
41 |
$496.41 |
| 99307 |
|
42 |
36 |
$494.59 |
| 77075 |
|
17 |
13 |
$491.67 |
| 90723 |
|
904 |
893 |
$489.92 |
| 84703 |
|
2,087 |
2,012 |
$482.49 |
| 90619 |
|
333 |
325 |
$472.35 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
500 |
460 |
$470.88 |
| 73060 |
|
141 |
127 |
$461.16 |
| 87075 |
|
2,534 |
2,365 |
$450.61 |
| 84466 |
|
122 |
118 |
$425.97 |
| 94690 |
|
26 |
26 |
$421.62 |
| 90744 |
|
808 |
795 |
$419.69 |
| 82248 |
|
363 |
333 |
$415.42 |
| 99356 |
|
12 |
12 |
$409.56 |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
1,921 |
1,844 |
$401.19 |
| 83521 |
|
610 |
526 |
$398.57 |
| 83605 |
|
3,741 |
3,395 |
$395.73 |
| G0316 |
Prolonged hospital inpatient or observation care evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99223, 99233, and 99236 for hospital inpatient or observation care evaluation and management services). (do not report g0316 on the same date of service as other prolonged services for evaluation and management 99358, 99359, 99418, 99415, 99416). (do not report g0316 for any time unit less than 15 minutes) |
25 |
22 |
$394.99 |
| 99336 |
|
18 |
15 |
$390.98 |
| 88344 |
|
284 |
271 |
$390.47 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
204 |
199 |
$379.93 |
| 87427 |
|
65 |
65 |
$367.96 |
| 85049 |
|
1,253 |
1,146 |
$362.12 |
| 85014 |
|
1,987 |
1,612 |
$354.95 |
| 87329 |
|
67 |
66 |
$345.05 |
| 87328 |
|
67 |
66 |
$343.01 |
| 94664 |
|
1,455 |
1,164 |
$338.64 |
| 80178 |
|
277 |
234 |
$336.73 |
| 72081 |
|
70 |
68 |
$336.44 |
| 87902 |
|
28 |
25 |
$336.32 |
| 93282 |
|
12 |
12 |
$318.53 |
| 86364 |
|
248 |
243 |
$318.28 |
| 86901 |
|
4,989 |
4,237 |
$318.28 |
| 84112 |
|
107 |
94 |
$317.25 |
| 87493 |
|
42 |
38 |
$313.44 |
| 86300 |
|
653 |
529 |
$310.50 |
| 84520 |
|
830 |
785 |
$310.44 |
| 87046 |
|
70 |
68 |
$306.68 |
| 12001 |
|
146 |
143 |
$296.69 |
| J1756 |
Injection, iron sucrose, 1 mg |
2,427 |
1,046 |
$290.81 |
| 46600 |
|
79 |
77 |
$290.06 |
| 87045 |
|
69 |
68 |
$287.80 |
| 82670 |
|
31 |
27 |
$285.43 |
| 86430 |
|
456 |
441 |
$276.54 |
| 87641 |
|
49 |
41 |
$268.70 |
| L8000 |
Breast prosthesis, mastectomy bra, without integrated breast prosthesis form, any size, any type |
28 |
24 |
$268.26 |
| 90674 |
|
12 |
12 |
$264.55 |
| 86923 |
|
95 |
68 |
$252.48 |
| 93882 |
|
13 |
12 |
$249.59 |
| C1769 |
Guide wire |
6,084 |
5,110 |
$245.47 |
| 86225 |
|
179 |
170 |
$242.14 |
| 90653 |
|
387 |
367 |
$242.05 |
| 86200 |
|
319 |
308 |
$242.03 |
| 96159 |
|
727 |
535 |
$231.56 |
| 86304 |
|
174 |
143 |
$230.60 |
| 93293 |
|
13 |
13 |
$226.33 |
| 85379 |
|
2,209 |
2,045 |
$213.40 |
| 86235 |
|
140 |
132 |
$205.65 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
16 |
16 |
$200.70 |
| 86334 |
|
375 |
340 |
$198.45 |
| 99100 |
|
156 |
141 |
$186.78 |
| 29125 |
|
109 |
104 |
$184.46 |
| 82952 |
|
72 |
72 |
$175.48 |
| 86762 |
|
181 |
177 |
$173.47 |
| 87640 |
|
43 |
40 |
$169.38 |
| 80504 |
|
127 |
121 |
$167.98 |
| 96381 |
|
12 |
12 |
$159.36 |
| J9196 |
Injection, gemcitabine hydrochloride (accord), not therapeutically equivalent to j9201, 200 mg |
25 |
12 |
$159.13 |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
18 |
14 |
$158.95 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
2,602 |
2,538 |
$157.29 |
| 87468 |
|
103 |
102 |
$154.52 |
| 87484 |
|
103 |
102 |
$154.52 |
| 87469 |
|
103 |
102 |
$154.52 |
| 84132 |
|
2,140 |
1,720 |
$153.78 |
| 99457 |
|
45 |
39 |
$151.70 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
315 |
297 |
$135.14 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
859 |
765 |
$134.56 |
| 87517 |
|
39 |
38 |
$129.46 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
3,646 |
3,369 |
$124.10 |
| J0736 |
Injection, clindamycin phosphate, 300 mg |
65 |
55 |
$122.68 |
| 73565 |
|
770 |
757 |
$120.06 |
| 93228 |
|
12 |
12 |
$116.76 |
| 96120 |
|
113 |
113 |
$115.42 |
| 51741 |
|
87 |
84 |
$115.42 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
666 |
550 |
$110.86 |
| 90715 |
|
5,718 |
5,452 |
$103.67 |
| 87478 |
|
55 |
55 |
$98.24 |
| 86255 |
|
25 |
25 |
$96.94 |
| 80197 |
|
20 |
12 |
$96.58 |
| 80069 |
|
35 |
30 |
$95.31 |
| 88302 |
|
85 |
75 |
$94.71 |
| 87430 |
|
485 |
470 |
$93.48 |
| A6212 |
Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing |
26 |
26 |
$90.00 |
| 88173 |
|
319 |
303 |
$85.09 |
| 76376 |
|
1,188 |
1,146 |
$82.02 |
| 90680 |
|
1,659 |
1,642 |
$79.18 |
| 92504 |
|
13 |
13 |
$77.93 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
1,058 |
836 |
$76.65 |
| G0101 |
Cervical or vaginal cancer screening; pelvic and clinical breast examination |
14 |
12 |
$76.00 |
| Q9957 |
Injection, perflutren lipid microspheres, per ml |
4,763 |
4,493 |
$75.84 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
100 |
98 |
$74.46 |
| 84155 |
|
346 |
323 |
$71.51 |
| 72080 |
|
42 |
42 |
$69.75 |
| 73000 |
|
30 |
29 |
$67.34 |
| 98925 |
|
17 |
16 |
$62.72 |
| 88142 |
|
134 |
132 |
$62.13 |
| 99173 |
|
32 |
32 |
$62.06 |
| G2012 |
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion |
17 |
16 |
$61.13 |
| 82150 |
|
125 |
118 |
$56.04 |
| G0297 |
Low dose ct scan (ldct) for lung cancer screening |
285 |
285 |
$52.60 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
3,315 |
2,737 |
$51.51 |
| 99442 |
|
14 |
14 |
$50.05 |
| 77387 |
|
6,147 |
603 |
$48.68 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
9,609 |
7,508 |
$46.79 |
| 51701 |
|
62 |
58 |
$45.98 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
1,047 |
982 |
$43.05 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
1,343 |
1,266 |
$40.42 |
| 80051 |
|
26 |
25 |
$35.85 |
| 85384 |
|
95 |
69 |
$34.72 |
| J1644 |
Injection, heparin sodium, per 1000 units |
8,083 |
4,261 |
$31.82 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
423 |
415 |
$30.10 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
2,465 |
2,102 |
$29.90 |
| 87184 |
|
14 |
14 |
$29.73 |
| 89051 |
|
609 |
492 |
$29.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
4,621 |
3,394 |
$27.42 |
| 86765 |
|
13 |
13 |
$26.19 |
| 94760 |
|
3,621 |
3,360 |
$19.98 |
| J0689 |
Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg |
119 |
85 |
$19.76 |
| 82657 |
|
55 |
53 |
$18.46 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
2,539 |
1,999 |
$18.32 |
| 86308 |
|
53 |
50 |
$17.57 |
| 83921 |
|
13 |
13 |
$16.83 |
| 82330 |
|
107 |
95 |
$16.42 |
| 87529 |
|
12 |
12 |
$15.91 |
| J2060 |
Injection, lorazepam, 2 mg |
2,526 |
1,977 |
$15.72 |
| 88185 |
|
709 |
651 |
$14.63 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
3,527 |
2,511 |
$13.62 |
| 86039 |
|
30 |
27 |
$11.16 |
| 87280 |
|
34 |
32 |
$10.94 |
| 77002 |
|
983 |
906 |
$8.85 |
| 86015 |
|
13 |
13 |
$8.07 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
451 |
435 |
$7.60 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
489 |
457 |
$7.60 |
| 84157 |
|
346 |
296 |
$7.53 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
2,148 |
1,704 |
$6.45 |
| 96368 |
|
2,362 |
1,479 |
$5.67 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
2,839 |
787 |
$5.67 |
| J0640 |
Injection, leucovorin calcium, per 50 mg |
1,097 |
570 |
$5.67 |
| J9190 |
Injection, fluorouracil, 500 mg |
1,498 |
795 |
$5.67 |
| J1630 |
Injection, haloperidol, up to 5 mg |
3,115 |
2,744 |
$5.24 |
| 96121 |
|
1,169 |
1,156 |
$5.00 |
| 85347 |
|
454 |
421 |
$4.28 |
| 82945 |
|
219 |
191 |
$3.93 |
| 84295 |
|
246 |
223 |
$3.00 |
| 88112 |
|
43 |
39 |
$2.39 |
| 96376 |
|
4,934 |
3,227 |
$1.67 |
| 99153 |
Mod sedat endo service >5yrs |
2,411 |
2,253 |
$0.00 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
3,160 |
1,655 |
$0.00 |
| C1726 |
Catheter, balloon dilatation, non-vascular |
852 |
787 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
5,415 |
4,274 |
$0.00 |
| G0269 |
Placement of occlusive device into either a venous or arterial access site, post surgical or interventional procedure (e.g., angioseal plug, vascular plug) |
219 |
214 |
$0.00 |
| 77001 |
|
606 |
577 |
$0.00 |
| 96377 |
|
766 |
528 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
2,857 |
2,642 |
$0.00 |
| 90474 |
|
378 |
374 |
$0.00 |
| 36416 |
|
199 |
195 |
$0.00 |
| J1940 |
Injection, furosemide, up to 20 mg |
178 |
95 |
$0.00 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
5,452 |
2,348 |
$0.00 |
| J1790 |
Injection, droperidol, up to 5 mg |
262 |
250 |
$0.00 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
1,989 |
1,428 |
$0.00 |
| J9045 |
Injection, carboplatin, 50 mg |
1,761 |
1,039 |
$0.00 |
| J9267 |
Injection, paclitaxel, 1 mg |
1,149 |
484 |
$0.00 |
| 90697 |
|
634 |
630 |
$0.00 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
637 |
629 |
$0.00 |
| 99439 |
|
494 |
372 |
$0.00 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
171 |
160 |
$0.00 |
| 90696 |
|
887 |
871 |
$0.00 |
| 91301 |
|
428 |
260 |
$0.00 |
| 96139 |
|
1,250 |
1,216 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
2,021 |
1,530 |
$0.00 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
120 |
78 |
$0.00 |
| 88341 |
|
1,907 |
1,738 |
$0.00 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
144 |
102 |
$0.00 |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
609 |
538 |
$0.00 |
| J1815 |
Injection, insulin, per 5 units |
883 |
589 |
$0.00 |
| 90698 |
|
1,508 |
1,488 |
$0.00 |
| A9503 |
Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries |
117 |
115 |
$0.00 |
| 88300 |
|
252 |
238 |
$0.00 |
| 91315 |
|
30 |
30 |
$0.00 |
| 91305 |
|
637 |
573 |
$0.00 |
| G8980 |
Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting |
274 |
262 |
$0.00 |
| G8988 |
Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
31 |
29 |
$0.00 |
| C1893 |
Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, other than peel-away |
127 |
124 |
$0.00 |
| A9555 |
Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries |
28 |
25 |
$0.00 |
| V2632 |
Posterior chamber intraocular lens |
78 |
65 |
$0.00 |
| 82553 |
|
16 |
14 |
$0.00 |
| 64494 |
|
101 |
93 |
$0.00 |
| 82077 |
|
302 |
284 |
$0.00 |
| 95012 |
|
77 |
77 |
$0.00 |
| J2790 |
Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.) |
165 |
161 |
$0.00 |
| A9270 |
Non-covered item or service |
504 |
459 |
$0.00 |
| C1889 |
Implantable/insertable device, not otherwise classified |
13 |
12 |
$0.00 |
| 00813 |
|
12 |
12 |
$0.00 |
| 82435 |
|
17 |
16 |
$0.00 |
| 91319 |
|
34 |
33 |
$0.00 |
| 82533 |
|
49 |
38 |
$0.00 |
| A4648 |
Tissue marker, implantable, any type, each |
192 |
185 |
$0.00 |
| 99417 |
Prolong home eval add 15m |
28 |
27 |
$0.00 |
| 88311 |
|
53 |
52 |
$0.00 |
| G8987 |
Self care functional limitation, current status, at therapy episode outset and at reporting intervals |
30 |
29 |
$0.00 |
| A9585 |
Injection, gadobutrol, 0.1 ml |
54 |
53 |
$0.00 |
| 99459 |
|
67 |
67 |
$0.00 |
| 91317 |
|
24 |
24 |
$0.00 |
| 12002 |
|
12 |
12 |
$0.00 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
31 |
29 |
$0.00 |
| 86301 |
|
34 |
28 |
$0.00 |
| 82103 |
|
13 |
13 |
$0.00 |
| C1778 |
Lead, neurostimulator (implantable) |
13 |
12 |
$0.00 |
| 77417 |
|
54 |
25 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
240 |
219 |
$0.00 |
| J3480 |
Injection, potassium chloride, per 2 meq |
70 |
41 |
$0.00 |
| 90381 |
|
16 |
15 |
$0.00 |
| 0154A |
|
15 |
15 |
$0.00 |
| 82360 |
|
37 |
37 |
$0.00 |
| 17250 |
|
16 |
12 |
$0.00 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
13 |
12 |
$0.00 |
| 91307 |
|
55 |
36 |
$0.00 |
| 90636 |
|
12 |
12 |
$0.00 |
| C1781 |
Mesh (implantable) |
12 |
12 |
$0.00 |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
3,026 |
2,950 |
$0.00 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
4,809 |
2,749 |
$0.00 |
| A6196 |
Alginate or other fiber gelling dressing, wound cover, sterile, pad size 16 sq. in. or less, each dressing |
764 |
529 |
$0.00 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
1,157 |
871 |
$0.00 |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
3,673 |
3,544 |
$0.00 |
| 90707 |
|
1,394 |
1,378 |
$0.00 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
13,368 |
13,146 |
$0.00 |
| 90648 |
|
1,894 |
1,868 |
$0.00 |
| 90633 |
|
2,233 |
2,201 |
$0.00 |
| 90700 |
|
1,145 |
1,123 |
$0.00 |
| 76942 |
|
1,297 |
1,115 |
$0.00 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
5,517 |
2,350 |
$0.00 |
| J3489 |
Injection, zoledronic acid, 1 mg |
565 |
529 |
$0.00 |
| 91300 |
|
8,280 |
7,196 |
$0.00 |
| C1760 |
Closure device, vascular (implantable/insertable) |
467 |
451 |
$0.00 |
| J1956 |
Injection, levofloxacin, 250 mg |
245 |
212 |
$0.00 |
| 88312 |
|
30 |
28 |
$0.00 |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
371 |
350 |
$0.00 |
| J1071 |
Injection, testosterone cypionate, 1 mg |
844 |
442 |
$0.00 |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
222 |
198 |
$0.00 |
| 88313 |
|
295 |
274 |
$0.00 |
| J0295 |
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
181 |
134 |
$0.00 |
| 91312 |
|
522 |
498 |
$0.00 |
| 76937 |
|
13 |
12 |
$0.00 |
| 91308 |
|
175 |
117 |
$0.00 |
| J2004 |
Injection, lidocaine hcl with epinephrine, 1 mg |
30 |
30 |
$0.00 |
| C1788 |
Port, indwelling (implantable) |
195 |
188 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
97 |
71 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
766 |
485 |
$0.00 |
| 78434 |
|
28 |
25 |
$0.00 |
| Q0245 |
Injection, bamlanivimab and etesevimab, 2100 mg |
53 |
53 |
$0.00 |
| 93356 |
|
128 |
125 |
$0.00 |
| 90671 |
|
46 |
46 |
$0.00 |
| C1729 |
Catheter, drainage |
263 |
232 |
$0.00 |
| J0744 |
Injection, ciprofloxacin for intravenous infusion, 200 mg |
47 |
38 |
$0.00 |
| 94727 |
|
84 |
77 |
$0.00 |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
1,216 |
1,174 |
$0.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
171 |
130 |
$0.00 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
108 |
105 |
$0.00 |
| J9263 |
Injection, oxaliplatin, 0.5 mg |
204 |
111 |
$0.00 |
| 91311 |
|
59 |
56 |
$0.00 |
| C1874 |
Stent, coated/covered, with delivery system |
43 |
39 |
$0.00 |
| 69220 |
|
12 |
12 |
$0.00 |
| J9060 |
Injection, cisplatin, powder or solution, 10 mg |
48 |
24 |
$0.00 |
| 85613 |
|
13 |
12 |
$0.00 |
| J9206 |
Injection, irinotecan, 20 mg |
110 |
50 |
$0.00 |
| J9370 |
Vincristine sulfate, 1 mg |
32 |
24 |
$0.00 |
| A9541 |
Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries |
44 |
42 |
$0.00 |
| 93321 |
|
13 |
13 |
$0.00 |
| G8989 |
Self care functional limitation, discharge status, at discharge from therapy or to end reporting |
29 |
28 |
$0.00 |
| 91321 |
|
68 |
68 |
$0.00 |
| 80179 |
|
29 |
28 |
$0.00 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
35 |
25 |
$0.00 |
| 80143 |
|
18 |
17 |
$0.00 |
| 86146 |
|
27 |
26 |
$0.00 |
| G8985 |
Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
13 |
13 |
$0.00 |
| 86147 |
|
26 |
25 |
$0.00 |
| 89050 |
|
36 |
30 |
$0.00 |
| 76813 |
|
12 |
12 |
$0.00 |